Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $891 at BofA Securities

July 30, 2026 1:36 PM
BofA Securities analyst Tazeen Ahmad raised the price target on Regeneron Pharma (NASDAQ: REGN) to $891.00 (from $856.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change